Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Baumgart

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Nature Microbiology|September 6, 2017
TRIM23 mediates virus-induced autophagy via activation of TBK1Konstantin M J Sparrer, Sebastian Gableske, Matthew A Zurenski, et al.
Bone Marrow Transplantation|December 14, 2004
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complicationsD W Beelen, R Trenschel, J Casper, et al.
Stem Cells (Dayton, Ohio)|May 6, 2016
Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast DifferentiationTareq Hossan, Sankari Nagarajan, Simon J Baumgart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignanciesM E Scheulen, R A Hilger, C Oberhoff, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
Molecular Cancer Therapeutics|October 5, 2019
The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer ModelsAntje M Wengner, Gerhard Siemeister, Ulrich Lücking, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 25, 2021
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer modelsClara Lemos, Volker K Schulze, Simon J Baumgart, et al.
Bone Marrow Transplantation|December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningJ Casper, J Holowiecki, R Trenschel, et al.
Human Reproduction (Oxford, England)|October 25, 2023
No major differences in perinatal and maternal outcomes between uninterrupted embryo culture in time-lapse system and conventional embryo cultureA Ahlström, K Lundin, D Cimadomo, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Nature Microbiology|September 6, 2017
TRIM23 mediates virus-induced autophagy via activation of TBK1Konstantin M J Sparrer, Sebastian Gableske, Matthew A Zurenski, et al.
Bone Marrow Transplantation|December 14, 2004
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complicationsD W Beelen, R Trenschel, J Casper, et al.
Stem Cells (Dayton, Ohio)|May 6, 2016
Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast DifferentiationTareq Hossan, Sankari Nagarajan, Simon J Baumgart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignanciesM E Scheulen, R A Hilger, C Oberhoff, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
Molecular Cancer Therapeutics|October 5, 2019
The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer ModelsAntje M Wengner, Gerhard Siemeister, Ulrich Lücking, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 25, 2021
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer modelsClara Lemos, Volker K Schulze, Simon J Baumgart, et al.
Bone Marrow Transplantation|December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningJ Casper, J Holowiecki, R Trenschel, et al.
Human Reproduction (Oxford, England)|October 25, 2023
No major differences in perinatal and maternal outcomes between uninterrupted embryo culture in time-lapse system and conventional embryo cultureA Ahlström, K Lundin, D Cimadomo, et al.
Pageof 7